HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

957.756

+15.7071.67%

Number of Gainers:6

Number of Losers:6

Number of Flat:1

PE:- -

High:970.674

Open:940.276

Low:931.220

Close:942.050

Volume:116.06M

Turnover:1.49B

Market Cap:158.30B

Float Cap:118.26B

Loading ...

Shanghai Haohai Biological Technology (SEHK:6826) Stock Hit By Margin Compression And Profit Drop

Simply Wall St.

HAOHAI BIOTEC Sets October Dividend Date for Interim Payout

China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution

3SBio (SEHK:1530) Stock Sees Margin Strength Clash With Profit Decline

Simply Wall St.

3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion

Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains

Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth

Press Release: Sunshine Guojian Releases 2026 Interim Report:

Sisram Medical (SEHK:1696) Stock Revenue Growth Masks Sharp Margin Compression

Simply Wall St.

China's 3SBio H1 Net Profit Falls on Higher Expenses

3SBio H1 Revenue RMB 4,526 Million

THOMSON REUTERS

Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion

Israeli Dermatology Firm Sol-Gel's Q2 Revenue Drops Sharply on Prior-Year IP Sale

Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business

China National Medical Products Administration: Approves 3S Guojian's Nonsteroidal Anti-Inflammatory Drug

THOMSON REUTERS

Earnings Report: China Medical System Holdings Limited Missed Revenue Estimates By 5.0%

Simply Wall St.

Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments

Sisram Medical H1 Revenue USD 171.4 Million

THOMSON REUTERS

Press Release: Sisram Medical Delivers Solid 2026 Interim Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":957.7562,"timestamp":1787299686774,"preClose":942.0496,"halted":0,"volume":116064927,"delay":0,"changeRate":0.016673,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":15.706604,"latestTime":"08-21 16:00:00","open":940.27594,"high":970.674,"low":931.22046,"amount":1485244213,"amplitude":0.041881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":1.223608,"peRate":11.34427,"turnoverRate":0.005692,"increases":4,"decrements":8,"flats":1,"marketCap":158295765624,"floatMarketCap":118260749624},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":970.674,"amplitude":0.041881,"preClose":942.0496,"low":931.22046,"pbRate":"1.223608","latestPrice":957.7562,"volume":116064927,"delay":0,"open":940.27594,"prevYearClose":1094.978,"prevWeekClose":957.712,"prevMonthClose":920.614,"prevQuarterClose":846.145,"fiveDayClose":957.712,"twentyDayClose":929.596,"sixtyDayClose":924.212,"secType":"PLATE","market":"HK","turnoverRate":0.005692,"peRate":11.34427,"marketCap":158295765624,"floatMarketCap":118260749624,"timestamp":1787299686774,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":6,"down":6,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661212564","title":"Shanghai Haohai Biological Technology (SEHK:6826) Stock Hit By Margin Compression And Profit Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212564","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212564?lang=en_us&edition=fundamental","pubTime":"2026-08-23 04:27","pubTimestamp":1787430458,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology heads into this earnings season with a stock that has slipped about 18% over the past three months, yet trades on a P/E of 20.7 that still sits below the broader Hong Kong biotech industry. The market has been fixated on dividend yield and headline earnings volatility.\nThe key issue in this Q2 release is the profit squeeze behind those headlines. Trailing net margin is 6.5% compared with 15.4% a year earlier, and the period includes a large one-off loss...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/shanghai-haohai-biological-technology-sehk6826-stock-hit-by","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6826/shanghai-haohai-biological-technology-shares/news/shanghai-haohai-biological-technology-sehk6826-stock-hit-by","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","06826","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180238161","title":"HAOHAI BIOTEC Sets October Dividend Date for Interim Payout","url":"https://stock-news.laohu8.com/highlight/detail?id=1180238161","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180238161?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:32","pubTimestamp":1787319132,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (06826) has announced that it will distribute an interim dividend of RMB 0.25 per share on October 16, 2026.The company confirmed the payment schedule in an official statement, marking...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","06826","VIG","BK4585","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661932892","title":"China's Haohai Biological H1 Revenue Falls, Partly Hurt by End of Brighten Optix Distribution","url":"https://stock-news.laohu8.com/highlight/detail?id=2661932892","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661932892?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:25","pubTimestamp":1787318735,"startTime":"0","endTime":"0","summary":"China's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distributionOverviewChina biomedical products maker's half-year revenue fell 9.8% yr/yr to RMB1.17 blnNet profit attrib","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0EM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2039709279.SGD","LU1008478684.HKD","BK1521","LU0072913022.USD","LU1226288170.HKD","BK0251","LU1993786604.SGD","LU0501845795.SGD","01093","LU0067412154.USD","LU1152091168.USD","LU1226287792.SGD","BK1593","LU0326950275.SGD","LU1807302812.USD","LU0315179316.USD","LU0880133367.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","IE0008369823.USD","BK1161","BK1515","IE0008368742.USD","LU1226287529.USD","LU1951186391.HKD","LU1226288253.USD","LU0314109678.HKD","688366","IE00BZ08YT58.USD","LU0140636845.USD","LU1328277881.USD","IE00B031HY20.USD","LU1226287875.USD","SG9999004220.SGD","IE00B543WZ88.USD","BK0239","IE00BZ08YS42.EUR","06826","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1960683339.HKD","KURE","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295126","title":"3SBio (SEHK:1530) Stock Sees Margin Strength Clash With Profit Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295126","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295126?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:20","pubTimestamp":1787318409,"startTime":"0","endTime":"0","summary":"3SBio stock closed at HK$17.83 on Friday, roughly flat over the past month, even as the latest half year numbers landed with a heavy focus on profitability. The headline is simple. H1 2026 brought in C¥4,525.985m of revenue, yet the story that matters is margin strength and what that might mean for future earnings power.\nInvestors now face a time horizon test. Trailing earnings growth and a P/E around 4.6x paint one picture. Forecasts that point to declining revenue and earnings over the next...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/3sbio-sehk1530-stock-sees-margin-strength-clash-with-profit","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1530/3sbio-shares/news/3sbio-sehk1530-stock-sees-margin-strength-clash-with-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","FEBU","PMDE","VOTE","BK1583","BK1161","BK1593","JOYT","VGFPF","HK0000165453.HKD","RGLO","GXDW","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250205","title":"3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250205?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:25","pubTimestamp":1787297118,"startTime":"0","endTime":"0","summary":"3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billion3SBio posted first-half 2026 revenue of RMB 4.53 billion, up 3.9% year over year.Net profit attribut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLb6tQZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1583","BK1593","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250247","title":"Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:24","pubTimestamp":1787297040,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, represent","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIB","HK0000165453.HKD","GDOC","HYLG","IDNA","BK4022","BK4232","BMED","R","BK1161","MEDX","BK1583","BK1593","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100118644","title":"Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1100118644","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100118644?lang=en_us&edition=fundamental","pubTime":"2026-08-21 12:09","pubTimestamp":1787285378,"startTime":"0","endTime":"0","summary":"Hong Kong equities advanced in Thursday's morning session, with the benchmark Hang Seng Index adding 184 points to trade 0.72% higher, while the Hang Seng Tech Index gained 0.50%. Total turnover in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02600","03115","LU0287142896.SGD","LU1251922891.USD","LU0702159699.USD","BK1592","HLDCY","LU1303224171.USD","LU1166156734.SGD","03750","01530","06656","07552","LU1152091754.HKD","BK1589","BK1543","002460","MCHmain","02837","07300","BK1509","LU1719994722.HKD","LU0359201885.HKD","LU1993786604.SGD","09115","LU1770034418.SGD","00012","300750","BK1240","07500","BK1116","03032","BK1518","HTImain","03417","HK0000286598.CNH","SG9999003461.SGD","HSTECH","HK0001040168.HKD","02800","LU0630314457.HKD","HK0001040143.USD","BK1601","LU0588546209.SGD","HK0000500386.USD","LU0572939691.SGD","03033","LU0210526637.USD","01378","BK1175","HK0000914686.HKD","03423","LU1960683339.HKD","03067","LU1224709979.USD","BK1610","BK1190","BK1149","BK1513","BK1129","BK1170","LU1023057109.AUD","LU1171460220.USD","BK1593","02833","BK1500","07226","BK1583","LU0264606111.USD","BK1161","LU0173614495.USD","BK1506","03088","09067","601600","HK0000252152.HKD","LU0345780950.USD","BK1523","02706","09696","00354","BK1594","01866","LU0572940350.SGD","LU1008478684.HKD","BK1526","BK1559","LU1807302812.USD","07200","BK1117","HHImain","06869","LU0359202008.SGD","LU0456827905.SGD","002466","83115","LU0051755006.USD","00189","HK0000165453.HKD","LU0307460666.USD","HSImain","03037","HK0000914660.USD","LU0737861699.HKD","SG9999014674.SGD","06896","HSI","01772","BK1568","HK0000252160.HKD","513600","LU1808992512.USD","02788","SG9999006597.SGD","BK1113","601869","SG9999001093.SGD","LU0067412154.USD","03419","LU2279858448.HKD","LU0880133367.SGD","BK1586","BK1155","LU0469268626.HKD","BK1522","LU1152091168.USD","82800","BK1207","LU0345781412.USD","LU0359201612.USD","09088","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185563343","title":"Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1185563343","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185563343?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:30","pubTimestamp":1787279417,"startTime":"0","endTime":"0","summary":"3SBIO (01530) shares climbed more than 7% in early trading, with the stock last up 6.85% at HK$17.63, on turnover of HK$395 million. The surge follows the company's release of its 2026 interim...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000165453.HKD","VXUS","BK1583","BK4585","BK4588","BK1593","01530","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258777","title":"Press Release: Sunshine Guojian Releases 2026 Interim Report:","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258777?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:00","pubTimestamp":1787270400,"startTime":"0","endTime":"0","summary":"Innovation-driven, Steady AdvancementSHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Today, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as \"Sunshine Guojian\", stock code: 688","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","688336","BK1161","BK4022","NVIB","IDNA","BK1593","HYLG","01530","BK1583","BK0239","BK4232","HK0000165453.HKD","R","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230539","title":"Sisram Medical (SEHK:1696) Stock Revenue Growth Masks Sharp Margin Compression","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230539","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230539?lang=en_us&edition=fundamental","pubTime":"2026-08-21 03:32","pubTimestamp":1787254347,"startTime":"0","endTime":"0","summary":"Sisram Medical stock has been under pressure, down about 27% over the past three months, yet today’s H1 2026 earnings story is not just about the share price slide. The headline is a clear profit squeeze. Revenue edged up to US$171.4m, but adjusted net profit was only US$5.04m, and the net result swung to a small loss. For a medical aesthetics equipment and injectables business that trades on a P/E of 11.1x and pays a 4.46% dividend, the real question now is how much short term margin pain...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-1696/sisram-medical-shares/news/sisram-medical-sehk1696-stock-revenue-growth-masks-sharp-mar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-1696/sisram-medical-shares/news/sisram-medical-sehk1696-stock-revenue-growth-masks-sharp-mar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1100","BK1593","01696","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660384532","title":"China's 3SBio H1 Net Profit Falls on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660384532","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660384532?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:37","pubTimestamp":1787236626,"startTime":"0","endTime":"0","summary":"China's 3SBio H1 net profit falls on higher expensesOverviewChina biopharmaceutical firm's half-year revenue rose 3.9% yr/yrNet profit attributable to shareholders fell 15.6% yr/yrGross profit increas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0M8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4149","BK1191","BK1583","BK4533","BK1515","IE00BZ08YS42.EUR","BK4567","HK0000165453.HKD","LU0069063385.USD","LU0154245756.USD","LU0472753341.HKD","01177","BK4585","LU0203347892.USD","BK1521","IE00BZ08YT58.USD","BK1161","LU0154245673.USD","LU0689626769.HKD","LU0289739343.SGD","LU0124676726.USD","LU0289961442.SGD","LU0203345920.USD","BK1593","LU0057025933.USD","BK4588","BK1589","LU2463526074.USD","LU0511384066.AUD","01530","MADE","IE00BZ08YR35.GBP","CMI","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660591238","title":"3SBio H1 Revenue RMB 4,526 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660591238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660591238?lang=en_us&edition=fundamental","pubTime":"2026-08-20 22:28","pubTimestamp":1787236090,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLX9N116F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","BK1161","01530","BK1583","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660287767","title":"Chinese Medical Device Maker Zylox-Tonbridge's Revenue Rises 31%, Aided by Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287767","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287767?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:40","pubTimestamp":1787233202,"startTime":"0","endTime":"0","summary":"Chinese medical device maker Zylox-Tonbridge's revenue rises 31%, aided by global expansionOverviewChina medical device maker's H1 revenue rose 31.1% yr/yr, driven by device sales growthNet profit for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0K9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1230","IE00BVYPNP33.GBP","SG9999015978.USD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","IE00BYV24P56.USD","BK1100","SG9999015945.SGD","IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BVYPNQ40.USD","BK1583","BK1191","IE00BMCWC346.EUR","02190","SG9999015986.USD","SG9999004220.SGD","BK1574","01696","BK1589","BK1593","IE00BGHQDM52.EUR","BK1515","01177","BK1521","BK1585","BK1587","00656","LU2488822045.USD","00867","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282565","title":"Israeli Dermatology Firm Sol-Gel's Q2 Revenue Drops Sharply on Prior-Year IP Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282565","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282565?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:50","pubTimestamp":1787230217,"startTime":"0","endTime":"0","summary":"Israeli dermatology firm Sol-Gel's Q2 revenue drops sharply on prior-year IP saleOverviewIsrael dermatology firm's Q2 revenue fell sharply yr/yr due to prior-year IP saleQ2 net loss and loss per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","SLGL","BK1593","BK1230","01696","BK4007","BK1100","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156555320","title":"Hong Kong Stock Movers | Sihuan Pharma Surges Over 6% on Strong H1 Profit Forecast and Expanding Aesthetic Medicine Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1156555320","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156555320?lang=en_us&edition=fundamental","pubTime":"2026-08-20 14:24","pubTimestamp":1787207055,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) shares climbed more than 6% in Hong Kong trading on Tuesday, with the stock last up 6.47% at HK$0.905, on turnover of HK$36.93 million.The rally follows the company's positive...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1593","BK1600","BK4585","BK1191","BK4588","BK1515","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660047222","title":"China National Medical Products Administration: Approves 3S Guojian's Nonsteroidal Anti-Inflammatory Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660047222","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660047222?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:58","pubTimestamp":1787191101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nP8N43G01E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1593","HK0000165453.HKD","01530","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660792204","title":"Earnings Report: China Medical System Holdings Limited Missed Revenue Estimates By 5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660792204","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660792204?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:48","pubTimestamp":1787179693,"startTime":"0","endTime":"0","summary":"The half-year results for China Medical System Holdings Limited ( HKG:867 ) were released last week, making it a good...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/earnings-report-china-medical-system-holdings-limited-missed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-867/china-medical-system-holdings-shares/news/earnings-report-china-medical-system-holdings-limited-missed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00867","VOTE","SG9999004220.SGD","SG9999015986.USD","RGLO","IE00BMCWC346.EUR","PMDE","BK1191","LU2488822045.USD","VGFPF","DECU","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","FEBU","BK1593","JOYT","IE00BYV24P56.USD","IE00BGHQDM52.EUR","SG9999015978.USD","SG9999015952.SGD","SG9999015945.SGD","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660400428","title":"Hong Kong's Sisram Medical H1 Profit Falls on China Injectables Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2660400428","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660400428?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:19","pubTimestamp":1787141959,"startTime":"0","endTime":"0","summary":"Hong Kong's Sisram Medical H1 profit falls on China injectables investmentsOverviewHong Kong medical aesthetics firm's H1 revenue rose 3.6% yr/yr to $171.4 mlnNet profit and adjusted net profit declin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G0FR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4567","BK1589","IE00BVYPNP33.GBP","LU2488822045.USD","IE00BGHQDM52.EUR","BK1230","LU0472753341.HKD","IE00BZ08YT58.USD","BK1191","BK1593","00656","BK1585","LU0057025933.USD","IE00BZ08YR35.GBP","BK4585","LU0154245673.USD","01177","LU0124676726.USD","SG9999015978.USD","00867","LU0689626769.HKD","IE00BZ08YS42.EUR","LU0203347892.USD","IE00BYV24P56.USD","BK4588","MADE","HK0000165453.HKD","CMI","SG9999015945.SGD","BK4149","SG9999015952.SGD","01696","BK1100","SG9999015986.USD","LU2463526074.USD","LU0511384066.AUD","BK1521","BK4533","IE00BVYPNQ40.USD","BK1515","LU0289739343.SGD","LU0069063385.USD","LU0289961442.SGD","SG9999004220.SGD","LU0154245756.USD","LU0203345920.USD","IE000M9KFDE8.USD","IE00BMCWC346.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428666","title":"Sisram Medical H1 Revenue USD 171.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428666?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:06","pubTimestamp":1787141189,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLX7485R1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","01696","BK1593","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428322","title":"Press Release: Sisram Medical Delivers Solid 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428322","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428322?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:00","pubTimestamp":1787140800,"startTime":"0","endTime":"0","summary":"Injectables Business Fuels Rapid Growth as APAC Drives International Revenue ExpansionHONG KONG, Aug. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd , a global wellness group offering Energy-Based Devices , injectables, and other complementary solutions, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 . During the Reporting Period, the Company achieved steady overall growth, propelled by accelerating momentum in its Injectables business and robust performance across the APAC region. These two growth drivers effectively mitigated headwinds in North America and broader macro uncertainties, underscoring the Company's operational stamina and strategic prudence.FINANCIAL HIGHLIGHTS-- Revenue was US$171.4 million, representing an increase of 3.6% year on. US$127.0 million, representing an increase of 16.7% YoY. Across the. region, revenues in APAC, Europe, and Middle East and Africa were US$78.4. million, representing a decrease of 21.6% YoY, wh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Sisram Medical Delivers Solid 2026 Interim Results","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIX","01696","CHAT","AIPO","BK1593","ARTY","QTOC","BK1585","VTHR","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}